# XORTX Therapeutics Inc.: Form 6-K, filed Oct 11, 2022

- Company: [XORTX Therapeutics Inc.](/companies/xrtx.md) (CIK 1729214)
- Form: 6-K
- Filed: 2022-10-11
- Accepted by EDGAR: Oct 7, 2022, 18:21 ET
- Period: 2022-10-07
- Accession: 0001171843-22-006510
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1729214/000117184322006510/f6k_100722.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1729214/000117184322006510/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1729214/000117184322006510/f6k_100722.htm

Filed Oct 11, 2022.
Source: SEC EDGAR, the filing index for accession 0001171843-22-006510. Last ingested by Listed: Nov 14, 2026, 22:48 ET. No prices; not investment advice.
